Monday
June 30, 2025
6:00 AM ET
Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)
Sunday
June 29, 2025
5:00 PM ET
Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025
Monday
May 12, 2025
6:00 AM ET
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
Monday
May 5, 2025
6:00 AM ET
Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025
Thursday
February 27, 2025
6:00 AM ET
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress
Thursday
February 20, 2025
4:05 PM ET
Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025